Literature DB >> 22307623

Cooperative effects of aminopeptidase N (CD13) expressed by nonmalignant and cancer cells within the tumor microenvironment.

Liliana Guzman-Rojas1, Roberto Rangel, Ahmad Salameh, Julianna K Edwards, Eleonora Dondossola, Yun-Gon Kim, Alan Saghatelian, Ricardo J Giordano, Mikhail G Kolonin, Fernanda I Staquicini, Erkki Koivunen, Richard L Sidman, Wadih Arap, Renata Pasqualini.   

Abstract

Processes that promote cancer progression such as angiogenesis require a functional interplay between malignant and nonmalignant cells in the tumor microenvironment. The metalloprotease aminopeptidase N (APN; CD13) is often overexpressed in tumor cells and has been implicated in angiogenesis and cancer progression. Our previous studies of APN-null mice revealed impaired neoangiogenesis in model systems without cancer cells and suggested the hypothesis that APN expressed by nonmalignant cells might promote tumor growth. We tested this hypothesis by comparing the effects of APN deficiency in allografted malignant (tumor) and nonmalignant (host) cells on tumor growth and metastasis in APN-null mice. In two independent tumor graft models, APN activity in both the tumors and the host cells cooperate to promote tumor vascularization and growth. Loss of APN expression by the host and/or the malignant cells also impaired lung metastasis in experimental mouse models. Thus, cooperation in APN expression by both cancer cells and nonmalignant stromal cells within the tumor microenvironment promotes angiogenesis, tumor growth, and metastasis.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22307623      PMCID: PMC3277167          DOI: 10.1073/pnas.1120790109

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  65 in total

1.  Co-expression of haemopoietic antigens on vascular endothelial cells: a detailed phenotypic analysis.

Authors:  E J Favaloro; N Moraitis; K Bradstock; J Koutts
Journal:  Br J Haematol       Date:  1990-04       Impact factor: 6.998

2.  Biochemical and functional characterization of aminopeptidase N expressed by human melanoma cells.

Authors:  A Menrad; D Speicher; J Wacker; M Herlyn
Journal:  Cancer Res       Date:  1993-03-15       Impact factor: 12.701

3.  Expression of aminopeptidase N in human endometrium and regulation of its activity by estrogen.

Authors:  E Seli; L M Senturk; O M Bahtiyar; U A Kayisli; A Arici
Journal:  Fertil Steril       Date:  2001-06       Impact factor: 7.329

4.  Expression and localization of aminopeptidase A, aminopeptidase N, and dipeptidyl peptidase IV in benign and malignant human prostate tissue.

Authors:  T Bogenrieder; C L Finstad; R H Freeman; C N Papandreou; H I Scher; A P Albino; V E Reuter; D M Nanus
Journal:  Prostate       Date:  1997-12-01       Impact factor: 4.104

5.  CD13 is a therapeutic target in human liver cancer stem cells.

Authors:  Naotsugu Haraguchi; Hideshi Ishii; Koshi Mimori; Fumiaki Tanaka; Masahisa Ohkuma; Ho Min Kim; Hirofumi Akita; Daisuke Takiuchi; Hisanori Hatano; Hiroaki Nagano; Graham F Barnard; Yuichiro Doki; Masaki Mori
Journal:  J Clin Invest       Date:  2010-08-09       Impact factor: 14.808

Review 6.  Microenvironmental regulation of metastasis.

Authors:  Johanna A Joyce; Jeffrey W Pollard
Journal:  Nat Rev Cancer       Date:  2008-03-12       Impact factor: 60.716

7.  Dipeptidyl peptidase IV (CD 26) and aminopeptidase N (CD 13) catalyzed hydrolysis of cytokines and peptides with N-terminal cytokine sequences.

Authors:  T Hoffmann; J Faust; K Neubert; S Ansorge
Journal:  FEBS Lett       Date:  1993-12-20       Impact factor: 4.124

8.  Metalloprotease activity of CD13/aminopeptidase N on the surface of human myeloid cells.

Authors:  R A Ashmun; A T Look
Journal:  Blood       Date:  1990-01-15       Impact factor: 22.113

9.  Inhibition of APN/CD13 leads to suppressed progressive potential in ovarian carcinoma cells.

Authors:  Mikio Terauchi; Hiroaki Kajiyama; Kiyosumi Shibata; Kazuhiko Ino; Akihiro Nawa; Shigehiko Mizutani; Fumitaka Kikkawa
Journal:  BMC Cancer       Date:  2007-07-27       Impact factor: 4.430

Review 10.  Aminopeptidase N in arterial hypertension.

Authors:  Robert S Danziger
Journal:  Heart Fail Rev       Date:  2007-11-16       Impact factor: 4.214

View more
  37 in total

1.  Surface markers of liver cancer stem cells and innovative targeted-therapy strategies for HCC.

Authors:  Lige Qiu; Hailiang Li; Sirui Fu; Xiaofang Chen; Ligong Lu
Journal:  Oncol Lett       Date:  2017-12-08       Impact factor: 2.967

2.  Bone marrow-derived CD13+ cells sustain tumor progression: A potential non-malignant target for anticancer therapy.

Authors:  Eleonora Dondossola; Angelo Corti; Richard L Sidman; Wadih Arap; Renata Pasqualini
Journal:  Oncoimmunology       Date:  2014-01-16       Impact factor: 8.110

3.  The X-ray crystal structure of human aminopeptidase N reveals a novel dimer and the basis for peptide processing.

Authors:  Alan H M Wong; Dongxia Zhou; James M Rini
Journal:  J Biol Chem       Date:  2012-08-29       Impact factor: 5.157

4.  Sustained release of endothelial progenitor cell-derived extracellular vesicles from shear-thinning hydrogels improves angiogenesis and promotes function after myocardial infarction.

Authors:  Carol W Chen; Leo L Wang; Samir Zaman; Jon Gordon; Maria F Arisi; Chantel M Venkataraman; Jennifer J Chung; George Hung; Ann C Gaffey; Lynn A Spruce; Hossein Fazelinia; Robert C Gorman; Steven H Seeholzer; Jason A Burdick; Pavan Atluri
Journal:  Cardiovasc Res       Date:  2018-06-01       Impact factor: 10.787

5.  Viral nanoparticles decorated with novel EGFL7 ligands enable intravital imaging of tumor neovasculature.

Authors:  Choi-Fong Cho; Lihai Yu; Tienabe K Nsiama; Alisha N Kadam; Arun Raturi; Sourabh Shukla; Giulio A Amadei; Nicole F Steinmetz; Leonard G Luyt; John D Lewis
Journal:  Nanoscale       Date:  2017-08-24       Impact factor: 7.790

6.  Tumor-specific delivery and therapy by double-targeted DTX-CMCS-PEG-NGR conjugates.

Authors:  Fengxi Liu; Min Li; Chunxi Liu; Yongjun Liu; Yanchao Liang; Fengshan Wang; Na Zhang
Journal:  Pharm Res       Date:  2013-09-17       Impact factor: 4.200

7.  AZGP1 and SPDEF mRNA expression differentiates breast carcinoma from ovarian serous carcinoma.

Authors:  Helene Tuft Stavnes; Dag André Nymoen; Anita Langerød; Arild Holth; Anne-Lise Børresen Dale; Ben Davidson
Journal:  Virchows Arch       Date:  2012-12-15       Impact factor: 4.064

8.  CD13-positive bone marrow-derived myeloid cells promote angiogenesis, tumor growth, and metastasis.

Authors:  Eleonora Dondossola; Roberto Rangel; Liliana Guzman-Rojas; Elena M Barbu; Hitomi Hosoya; Lisa S St John; Jeffrey J Molldrem; Angelo Corti; Richard L Sidman; Wadih Arap; Renata Pasqualini
Journal:  Proc Natl Acad Sci U S A       Date:  2013-12-02       Impact factor: 11.205

Review 9.  Ligand-targeted theranostic nanomedicines against cancer.

Authors:  Virginia J Yao; Sara D'Angelo; Kimberly S Butler; Christophe Theron; Tracey L Smith; Serena Marchiò; Juri G Gelovani; Richard L Sidman; Andrey S Dobroff; C Jeffrey Brinker; Andrew R M Bradbury; Wadih Arap; Renata Pasqualini
Journal:  J Control Release       Date:  2016-01-06       Impact factor: 9.776

10.  Pyrococcus horikoshii TET2 peptidase assembling process and associated functional regulation.

Authors:  Alexandre Appolaire; Eva Rosenbaum; M Asunción Durá; Matteo Colombo; Vincent Marty; Marjolaine Noirclerc Savoye; Anne Godfroy; Guy Schoehn; Eric Girard; Frank Gabel; Bruno Franzetti
Journal:  J Biol Chem       Date:  2013-05-21       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.